Pfizer CAPE ratio
The current Shiller CAPE Ratio for Pfizer Inc is 6.695 (2026-01-09), with an average CAPE of 11.648. The lowest CAPE Ratio was 5.758 on 2025-04-10, and the highest was 20.524 on 2021-12-16.
Pfizer’s CAPE ratio compares the company’s stock price to its average earnings over the past 10 years, adjusted for inflation. This metric helps investors assess whether Pfizer is overvalued or undervalued relative to its long-term earnings potential. A higher CAPE ratio may indicate the stock is overpriced, while a lower ratio could suggest it’s undervalued. Given Pfizer’s role in the pharmaceutical industry, factors like drug development success and market dynamics heavily influence its CAPE ratio.
CAPE Statistics for Pfizer (2006-07-03 to 2026-01-09)
- Current CAPE: 6.695 (0.75%)
- Min: 5.758 (2025-04-10)
- Max: 20.524 (2021-12-16)
- Mean: 11.648
- Median: 12.284
CAPE vs Forward Returns — Pfizer
Pfizer Metrics (2016-01-11 → 2026-01-09)
- Current Price: $25.48 (0.75%)
- YTD Return: 1.19%
- Annualized Volatility YTD: 10%
- Average Annual Return: 1.35%
- CAGR: -1.45%
10-Year Performance for Pfizer Inc
Cumulative Return
Annual Returns
Quarterly Returns
Rolling Volatility (6M)
Return Distribution & Tail Risk (VaR 95/99)
VaR 95%: %
VaR 99%: %